Nifty
Sensex
:
:
13258.55
45079.55
124.65 (0.95%)
446.90 (1.00%)

Pharmaceuticals & Drugs

Rating :
50/99  (View)

BSE: 541400 | NSE: Not Listed

90.00
-0.40 (-0.44%)
04-Dec-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  92.75
  •  92.90
  •  87.50
  •  90.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  763
  •  0.69
  •  131.45
  •  42.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 146.18
  • 17.62
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 232.08
  • N/A
  • 0.93

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.26%
  • 1.15%
  • 31.01%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 34.58%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.89
  • 0.68
  • 0.60

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.20
  • -4.98
  • -8.25

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -15.59
  • -8.34
  • -44.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
88
68
30%
70
67
5%
69
95
-27%
73
98
-25%
Expenses
75
63
19%
60
64
-7%
62
84
-26%
65
85
-24%
EBITDA
13
5
176%
11
3
240%
7
10
-33%
8
13
-37%
EBIDTM
14%
7%
15%
5%
14%
11%
11%
13%
Other Income
0
0
-55%
1
1
-41%
2
1
204%
1
1
-14%
Interest
3
3
-16%
3
3
-9%
3
2
21%
3
3
29%
Depreciation
4
3
11%
4
3
15%
4
3
20%
4
3
36%
PBT
1
-2
-
4
-2
-
2
5
-54%
2
8
-80%
Tax
0
-1
-
1
-3
-
0
3
-94%
0
2
-94%
PAT
1
-1
-
3
0
3544%
2
2
0%
2
6
-74%
PATM
1%
-1%
5%
0%
7%
2%
2%
6%
EPS
0.74
-0.38
-
2.02
0.05
3940%
1.42
1.42
0%
0.94
3.64
-74%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
301
278
335
273
235
269
266
Net Sales Growth
-8%
-17%
23%
16%
-12%
1%
 
Cost Of Goods Sold
4,766
143
160
141
120
158
182
Gross Profit
-4,465
135
176
132
115
111
85
GP Margin
-1,483%
48%
52%
48%
49%
41%
32%
Total Expenditure
263
255
293
238
204
239
245
Power & Fuel Cost
-
7
7
6
5
6
6
% Of Sales
-
3%
2%
2%
2%
2%
2%
Employee Cost
-
51
48
41
33
31
23
% Of Sales
-
18%
14%
15%
14%
11%
9%
Manufacturing Exp.
-
11
14
8
8
7
7
% Of Sales
-
4%
4%
3%
3%
3%
3%
General & Admin Exp.
-
12
15
11
10
9
6
% Of Sales
-
4%
4%
4%
4%
3%
2%
Selling & Distn. Exp.
-
25
46
28
23
22
17
% Of Sales
-
9%
14%
10%
10%
8%
6%
Miscellaneous Exp.
-
6
5
4
5
7
4
% Of Sales
-
2%
1%
1%
2%
2%
1%
EBITDA
38
23
42
35
31
29
21
EBITDA Margin
13%
8%
13%
13%
13%
11%
8%
Other Income
4
5
2
3
6
4
2
Interest
12
13
11
9
10
14
10
Depreciation
15
14
11
10
9
9
7
PBT
10
0
22
19
18
11
6
Tax
1
-3
7
6
-1
0
-5
Tax Rate
15%
-4,614%
30%
23%
-6%
5%
19%
PAT
8
3
15
19
19
5
-22
PAT before Minority Interest
8
3
15
19
19
5
-22
Minority Interest
0
0
0
0
0
0
0
PAT Margin
3%
1%
5%
7%
8%
2%
-8%
PAT Growth
8%
-78%
-20%
3%
265%
124%
 
EPS
5.11
2.04
9.47
11.80
11.48
3.15
-13.34

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
154
151
137
118
99
94
Share Capital
16
16
8
8
8
8
Total Reserves
137
134
128
110
90
86
Non-Current Liabilities
23
20
17
18
35
38
Secured Loans
27
19
16
27
34
37
Unsecured Loans
0
3
4
1
1
1
Long Term Provisions
0
0
0
0
0
0
Current Liabilities
143
156
141
113
124
134
Trade Payables
66
72
66
45
47
64
Other Current Liabilities
27
39
25
18
17
17
Short Term Borrowings
50
40
50
47
56
51
Short Term Provisions
1
6
0
3
4
2
Total Liabilities
320
328
295
250
257
266
Net Block
116
106
94
89
92
87
Gross Block
159
136
113
98
120
108
Accumulated Depreciation
43
30
19
9
28
20
Non Current Assets
138
132
122
96
102
97
Capital Work in Progress
10
13
8
4
3
6
Non Current Investment
0
0
0
0
0
0
Long Term Loans & Adv.
10
12
17
2
6
4
Other Non Current Assets
2
1
2
1
0
0
Current Assets
182
195
173
154
155
169
Current Investments
0
0
0
0
0
0
Inventories
56
55
52
35
38
46
Sundry Debtors
68
93
89
88
89
81
Cash & Bank
4
3
4
6
6
8
Other Current Assets
54
1
1
1
23
34
Short Term Loans & Adv.
47
43
28
24
21
34
Net Current Assets
39
39
32
41
32
35
Total Assets
320
328
295
250
257
266

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
22
35
37
32
22
PBT
0
22
25
18
5
Adjustment
26
24
13
21
29
Changes in Working Capital
1
-10
3
-4
-11
Cash after chg. in Working capital
27
36
41
35
23
Interest Paid
0
0
0
0
0
Tax Paid
-5
-1
-4
-2
-1
Other Direct Exp. Paid
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
Cash From Investing Activity
-19
-21
-26
-7
-12
Net Fixed Assets
-19
-22
-20
22
Net Investments
-4
-4
0
0
Others
4
6
-6
-29
Cash from Financing Activity
-3
-15
-10
-25
-10
Net Cash Inflow / Outflow
0
-1
1
0
0
Opening Cash & Equivalents
0
1
0
1
1
Closing Cash & Equivalent
1
0
1
0
1

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
95
93
84
73
61
59
ROA
1%
5%
7%
7%
2%
-8%
ROE
2%
11%
15%
17%
5%
-23%
ROCE
5%
15%
16%
14%
10%
-9%
Fixed Asset Turnover
1.88
2.70
2.60
2.21
2.43
2.56
Receivable days
106
99
118
134
112
108
Inventory Days
73
58
58
55
55
61
Payable days
97
88
87
86
87
96
Cash Conversion Cycle
82
69
89
104
80
73
Total Debt/Equity
0.59
0.52
0.60
0.68
0.98
0.99
Interest Cover
1
3
4
3
1
-2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.